Stay updated on Avelumab in Chemo-resistant GTN Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.

Latest updates to the Avelumab in Chemo-resistant GTN Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedA general NIH notice about a terminology transition appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The clinical trial page still displays a 403 error.SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedLocations and contact information, as well as study record dates and results sections, have been removed. The page now presents a leaner view of the study details with fewer contextual details about where and when the study occurs and its history.SummaryDifference18%

- Check42 days agoChange DetectedThe page's revision tag was updated to v3.7.0, signaling a version update of the study entry. This change reflects a metadata update rather than a modification to the study details.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a platform update. This change affects the underlying system version without altering study details or visible content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page revision has been updated from v3.6.4 to v3.6.5, indicating a minor maintenance update to the page without affecting study details or participation information.SummaryDifference0.1%

Stay in the know with updates to Avelumab in Chemo-resistant GTN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Chemo-resistant GTN Clinical Trial page.